{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:23:32Z","timestamp":1787887412085,"version":"build-2784847793"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.msard.2025.106337","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:22:32Z","timestamp":1739838152000},"page":"106337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Infectious mononucleosis is a more realistic target for preventing multiple sclerosis"],"prefix":"10.1016","volume":"95","author":[{"given":"Gavin","family":"Giovannoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H","family":"Hawkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Lechner-Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Ann","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106337_bib0001","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1474-4422(22)00471-9","article-title":"Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy","volume":"22","author":"Aloisi","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106337_bib0002","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis. Part I: the role of infection","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106337_bib39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11481-010-9201-3","article-title":"Epstein-barr virus infection and multiple sclerosis: a review","volume":"5","author":"Ascherio","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.msard.2025.106337_bib0003","doi-asserted-by":"crossref","first-page":"7472","DOI":"10.1016\/j.vaccine.2020.09.074","article-title":"How acceptable is adolescent self-consent for the HPV vaccination: findings from a qualitative study in south-west England","volume":"38","author":"Audrey","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.msard.2025.106337_bib0004","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/infdis\/jit321","article-title":"Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition","volume":"208","author":"Balfour","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.msard.2025.106337_bib0005","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0120","article-title":"Characteristics of children and adolescents with multiple sclerosis","volume":"138","author":"Belman","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.msard.2025.106337_bib40","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.msard.2025.106337_bib0006","series-title":"\u201cSafety signal\u201d in Moderna's RSV Vaccine Studies Halts Trials of Other Vaccines for Childhood Killer [WWW Document]","author":"Cohen","year":"2024"},{"key":"10.1016\/j.msard.2025.106337_bib0007","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179483","article-title":"Therapeutic vaccines for herpesviruses","volume":"134","author":"Cohen","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.msard.2025.106337_bib0009","doi-asserted-by":"crossref","first-page":"e70076","DOI":"10.1002\/iid3.70076","article-title":"Acceptance-hesitancy of COVID-19 vaccination and factors affecting it in adults: systematic review study","volume":"12","author":"Darbandi","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.msard.2025.106337_bib0010","first-page":"211","article-title":"Infectious mononucleosis","volume":"390","author":"Dunmire","year":"2015","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"10.1016\/j.msard.2025.106337_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867918","article-title":"Four decades of prophylactic EBV vaccine research: a systematic review and historical perspective","volume":"13","author":"Escalante","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.msard.2025.106337_bib0012","article-title":"Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study","volume":"385","author":"Falcaro","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.msard.2025.106337_bib0013","series-title":"Mononucleosis in children","author":"Felman","year":"2024"},{"key":"10.1016\/j.msard.2025.106337_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103636","article-title":"Is EBV the cause of multiple sclerosis?","volume":"58","author":"Giovannoni","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106337_bib0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/13524585241237707","article-title":"Risk of multiple sclerosis in individuals with infectious mononucleosis: a national population-based cohort study using hospital records in England, 2003-2023","volume":"30","author":"Goldacre","year":"2024","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106337_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012496","article-title":"An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis","volume":"5","author":"Handel","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2025.106337_bib0016","article-title":"Epstein-Barr Virus and systemic autoimmune diseases","volume":"11","author":"Houen","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.msard.2025.106337_bib0017","doi-asserted-by":"crossref","first-page":"e1954","DOI":"10.1212\/WNL.0000000000005612","article-title":"Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women","volume":"90","author":"Koch-Henriksen","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106337_bib0018","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1186\/s12889-020-09049-x","article-title":"Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom","volume":"20","author":"Kuri","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.msard.2025.106337_bib0019","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2025.106337_bib0021","article-title":"Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.msard.2025.106337_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00705-024-06095-3","article-title":"GB and gH\/gL fusion machinery: a promising target for vaccines to prevent Epstein-Barr virus infection","volume":"169","author":"Liu","year":"2024","journal-title":"Arch. Virol."},{"key":"10.1016\/j.msard.2025.106337_bib42","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1086\/650456","article-title":"Infectious mononucleosis in university students in the United kingdom: evaluation of the clinical features and consequences of the disease","volume":"50","author":"Macsween","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.msard.2025.106337_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.887794","article-title":"The potential for EBV vaccines to prevent multiple sclerosis","volume":"13","author":"Maple","year":"2022","journal-title":"Front Neurol."},{"key":"10.1016\/j.msard.2025.106337_bib0023","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1057\/s41599-022-01245-x","article-title":"Aggressive behaviour of anti-vaxxers and their toxic replies in English and Japanese","volume":"9","author":"Miyazaki","year":"2022","journal-title":"Humanit. Soc. Sci. Commun."},{"key":"10.1016\/j.msard.2025.106337_bib0024","series-title":"Mononucleosis","author":"Mohseni","year":"2025"},{"key":"10.1016\/j.msard.2025.106337_bib0008","unstructured":"NHS England Digital. Coverage Statistics 2022-23 [WWW Document], n.d. URL https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/nhs-immunisation-statistics\/england-2022-23\/6in-1-vaccine (accessed 2.12.25)."},{"key":"10.1016\/j.msard.2025.106337_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/jpm14040400","article-title":"Challenges in diagnosis and therapeutic strategies in late-onset multiple sclerosis","volume":"14","author":"Nociti","year":"2024","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.msard.2025.106337_bib0026","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MAJ.0b013e318236e02d","article-title":"Acute or chronic life-threatening diseases associated with Epstein-Barr virus infection","volume":"343","author":"Okano","year":"2012","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.msard.2025.106337_bib0027","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/1352458512449682","article-title":"The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis","volume":"19","author":"Pakpoor","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106337_bib0028","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1016\/j.vaccine.2009.01.069","article-title":"Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics","volume":"27","author":"Poland","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.msard.2025.106337_bib0029","article-title":"One-year follow-up of young people with ME\/CFS following infectious mononucleosis by Epstein-Barr virus","volume":"11","author":"Pricoco","year":"2023","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.msard.2025.106337_bib0030","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/jnnp.2010.232108","article-title":"Geography of hospital admissions for multiple sclerosis in England and comparison with the geography of hospital admissions for infectious mononucleosis: a descriptive study","volume":"82","author":"Ramagopalan","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106337_bib0031","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.msard.2025.106337_bib0032","series-title":"An Issue of Pediatric Clinics of North America","article-title":"Vaccine hesitancy","author":"Szilagyi","year":"2023"},{"key":"10.1016\/j.msard.2025.106337_bib0033","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106337_bib41","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1016\/j.cell.2023.11.015","article-title":"Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis","volume":"186","author":"Vietzen","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.msard.2025.106337_bib0034","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1471-2334-14-151","article-title":"The epidemiology of infectious mononucleosis in Northern Scotland: a decreasing incidence and winter peak","volume":"14","author":"Visser","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.msard.2025.106337_bib0035","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106337_bib0036","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1086\/518615","article-title":"What causes prolonged fatigue after infectious mononucleosis: and does it tell us anything about chronic fatigue syndrome?","volume":"196","author":"White","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.msard.2025.106337_bib0037","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","article-title":"Estimating the global burden of Epstein-Barr virus-related cancers","volume":"148","author":"Wong","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482500080X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482500080X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:49:15Z","timestamp":1741841355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482500080X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":42,"alternative-id":["S221103482500080X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106337","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infectious mononucleosis is a more realistic target for preventing multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106337"}}